Autoimmune Response to IGF2 mRNA-Binding Protein 2 (IMP2/p62) in Breast Cancer

Scandinavian Journal of Immunology

Volumn 81, Issue 6, 2015, Pages 502-507

  Liu, W ^a,b   Li, Y ^b   Wang, B ^a,b   Dai, L ^b   Qian, W ^b,c   Zhang, J Y ^b,c  

^a Department of Orthopedics   (China)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c NORTHEASTERN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BINDING PROTEIN; IGF2 MRNA BINDING PROTEIN 2; PROTEIN P62; UNCLASSIFIED DRUG; IGF2BP2 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; AUTOIMMUNITY; BREAST CANCER; BREAST TUMOR; CANCER TISSUE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; BLOOD; CONFOCAL MICROSCOPY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METABOLISM; TISSUE MICROARRAY; TUMOR CELL LINE;

AUTOANTIBODIES; AUTOIMMUNITY; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; RNA-BINDING PROTEINS; TISSUE ARRAY ANALYSIS;

EID: 84929174910     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12285     Document Type: Article

References (16)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin 2013;63:11-30.
2. Tan HT, Lee YH, Chung MC. Cancer proteomics. Mass Spectrom Rev 2012;31:583-605.
3. Tan EM. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 2001;108:1411-5.
4. Tan EM, Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 2008;222:328-40.
5. Old LJ, Chen YT. New paths in human cancer serology. J Exp Med 1998;187:1163-7.
6. Zhang JY, Chan EK, Peng XX et al. Autoimmune responses to mRNA binding proteins IMP2/p62 and koc in diverse malignancies. Clin Immunol 2001;100:149-56.
7. Lu M, Nakamura RM, Dent ED et al. Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis. Am J Pathol 2001;159:945-53.
8. Zhang JY, Chan EKL, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999;189:1101-10.
9. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC. A family of insulin-like growth factor II mRNA binding proteins represses translation in late development. Mol Cell Biol 1999;19:1262-70.
10. Mueller-Pillasch F, Lacher U, Wallrap C et al. Cloning of a gene highly expressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997;14:2729-33.
11. Liao B, Hu Y, Herrick DJ, Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005;280:18517-24.
12. Himoto T, Kuriyama S, Zhang JY, Chan EKL, Nishioka M, Tan EM. Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Int J Oncol 2005;26:311-7.
13. Ross J, Lemm I, Berberet B. Overexpression of an mRNA-binding protein in human colorectal cancer. Oncogene 2001;20:6544-50.
14. Bell JL, Wächter K, Mühleck B et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BP2s): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 2013;70:2657-75.
15. Samy N, Ragab HM, El Maksoud NA, Shaalan M. Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up. Cancer Biomark 2010;6:63-72.
16. Liu W, De La Torre IG, Gutiérrez-Rivera MC et al. Detection of autoantibodies to multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Tumour Biol 2015;36:1307-12.